RONALD TERRELL: Open Payments
NPI 1518906122 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 10 payments from 7 companies in 2025. Trend: 2023 $352 · 2024 $160 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $90 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| PFIZER INC. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
Products named: FARXIGA, REXULTI, CAPLYTA, FANAPT, NURTEC ODT, JARDIANCE, HETLIOZ, PAXLOVID.
Industry payments across OH — which companies pay providers there.
